Helander A, Löwenmo C, Beck O
Karolinska Institute, Department of Clinical Neuroscience, St Görans Hospital, Stockholm, Sweden.
J Pharm Biomed Anal. 1995 Apr;13(4-5):651-4. doi: 10.1016/0731-7085(95)01287-u.
The aim of the present study was to develop a high-performance liquid chromatographic (HPLC) method for determination of the serotonin metabolite 5-hydroxytryptophol (5HTOL) in human urine. 5HTOL was liberated from its conjugated form by enzymatic hydrolysis and isolated by a sample clean-up procedure on a small Sephadex G-10 column. The eluate was injected onto an isocratically eluted C18 reversed-phase column and 5HTOL was converted into a fluorescent oxazole derivative by on-line post-column reaction with benzylamine in the presence of potassium hexacyanoferrate(III). The limit of detection was about 10 nM and the intra-assay coefficients of variation were below 4% with urine samples and standard solutions. The results indicate that the method can be used as a screening method to discriminate between normal and elevated levels of total (free + conjugated) 5HTOL in urine.
本研究的目的是开发一种高效液相色谱(HPLC)方法,用于测定人尿中血清素代谢物5-羟色醇(5HTOL)。5HTOL通过酶促水解从其共轭形式中释放出来,并通过在小型Sephadex G-10柱上的样品净化程序进行分离。将洗脱液注入等度洗脱的C18反相柱,在六氰合铁(III)酸钾存在下,5HTOL通过与苄胺的在线柱后反应转化为荧光恶唑衍生物。检测限约为10 nM,尿样和标准溶液的批内变异系数低于4%。结果表明,该方法可作为一种筛选方法,用于区分尿中总(游离+共轭)5HTOL的正常水平和升高水平。